The Russian vaccine is an adenoviral vector vaccine, not an mRNA “vaccine” like Pfizer and Moderna. The vaccine was found to be 91.6% effective in generating immunity.
Published by markskidmore
Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times. View more posts